Evidence map›Paper›PMID 33932139›Full record

ReviewMolecular genetics & genomic medicine2021

Costello syndrome with special cutaneous manifestations and HRAS G12D mutation: A case report and literature review.

Wen Qian, Meijie Zhang, Hequn Huang, Yihe Chen, Gajin Park, Ni Zeng, Yueyue Li, Qian Lu, Dan Luo

Open access · goldAbstract readCase ReportsReview
In one paragraph

Review in Molecular genetics & genomic medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 10 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Wen QianDepartment of Dermatology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.ORCID 0000-0001-6600-8249
Meijie ZhangDepartment of Mycology, Institute of Dermatology, Chinese Academy of Medical Science and Peking Union Medical College, Nanjing, China.
Hequn HuangDepartment of Dermatology, No. 1 Hospital and Key Laboratory of Dermatology, Ministry of Education, Anhui Medical University, Hefei, China.
Yihe ChenDepartment of Dermatology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Gajin ParkDepartment of Dermatology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Ni ZengDepartment of Dermatology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Yueyue LiDepartment of Dermatology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Qian LuDepartment of Dermatology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Dan LuoDepartment of Dermatology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Jiangsu Province Hospital · CNAnhui Medical University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCostello syndrome (CS, OMIM 218040) is a rare congenital disorder caused by mutations in HRAS. Previous studies reported that approximately 80% of patients with CS share the same pathogenic variant in HRAS gene in c.34G> A (p.G12S). Here, we report a CS patient with c.34G> A (p.G12D) variant in HRAS gene and she presented with special manifestation. METHODS AND

resultsWe describe a 31-year-old female patient who presented with distinctive facial appearance, intellectual disability, dental abnormalities, hyperkeratosis of palmer and planter, loose skin at birth, papillomata on the face and nipples. The whole-exome sequencing (WES) technology provided by Haotian Biotechnology (China) confirmed p.G12D variant in HRAS gene. To elucidate the typical features of CS with p.G12D variant, we further reviewed these previously reported cases and found that patients with G12D variant died within three months after birth due to multiple organ failure. They had the typical facial characteristics, failure to thrive, skin and cardiac abnormalities, and gene testing confirmed the diagnosis of CS.

conclusionTo the best of our knowledge, this is the first article to report a patient with a p.G12D variant that had special but mild manifestation. Moreover, this report and literature review casts new light on the clinical features of p.G12D variant.

Indexed as

PhenotypeAdultCostello SyndromeFemaleHeterozygoteHumansMutation, MissenseProto-Oncogene Proteins p21(ras)SkinHRAS protein, humanProto-Oncogene Proteins p21(ras)Costello syndromeheterozygous variantsHRAS variantp.G12D

Identifiers

PMID33932139
PMCPMC8222857
OpenAlexW3159897925

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.